Chapter Six - THE DRUG LORDS

CHAPTER SIX

THE DRUG LORDS

MEDICINE IS SUPPOSED to save lives.
But in this system, it prints money first.

Pharmaceuticals aren’t just part of the economy, they are the economy. The U.S. spends more per capita on healthcare than any other nation on earth, and still ranks lower in life expectancy, chronic illness, and medical bankruptcy than most of the developed world.

That isn’t an accident. That’s the model.

And at the top of that model sit a handful of corporations that control the entire pipeline from research to regulation to retail.

Start with Pfizer. Not because they’re the worst, but because they’re the blueprint. Pfizer’s rise came from mastering patents, not breakthroughs. They didn’t invent penicillin, they figured out how to mass-produce it. They didn’t discover Viagra, they stumbled into it during a failed angina trial, then built it into a billion-dollar brand. Their skill wasn’t science. It was sales.

Same story with Johnson & Johnson. Most people know them for baby shampoo. But their real money came from medical devices and branded drugs. For decades, they sold opioids through their subsidiary Janssen, aggressively marketing them to doctors while downplaying addiction risk. That campaign helped fuel the opioid crisis and they knew it. Internal documents showed deliberate efforts to reframe dependence as “pseudo-addiction,” requiring more opioids, not fewer.

Then there’s Merck, one of the oldest pharma giants. Merck made headlines for Vioxx, a painkiller that caused thousands of heart attacks before being pulled from the market. By the time lawsuits hit, they’d already banked billions.

Moderna is newer, but the model didn’t change. Their mRNA COVID vaccine was built on government-funded research, turbocharged by Operation Warp Speed, and sold back to the public at historic margins. They went from obscure startup to multi-billion-dollar juggernaut in under two years without ever bringing a product to market before that.

This is the throughline.

Most major drug companies don’t invent new drugs. They acquire, rebrand, patent, and sue. They buy out smaller labs, shelve unprofitable cures, and invest more in marketing than in R&D. The average cost of a new drug isn’t driven by science, it’s driven by lawyers, lobbyists, and the licensing system.

That system runs through the FDA.

The FDA is supposed to regulate pharma. But its budget is now largely funded by the companies it regulates through “user fees” for drug approval applications. That means the gatekeeper is on the payroll of the people it's supposed to keep in check.

So approvals get rushed. Warnings get softened. Side effects get buried in fine print. And once a drug hits the market, there’s no real incentive to monitor long-term harm, especially when class-action settlements get calculated into the business model.

The money isn’t in cures anyway. It’s in chronic conditions. Diabetes, heart disease, depression, anxiety, autoimmune disorders, anything that requires a daily pill is worth infinitely more than a one-time fix.

That’s why pharma invests in downstream treatment, not upstream prevention. They don’t need you to die. They just need you to stay sick in a manageable, medicated way.

This is also why they fight like hell to protect intellectual property. Even when a drug costs pennies to produce, they’ll charge thousands as long as they have exclusivity. That’s how Gilead priced their Hepatitis C cure at $84,000. That’s how Martin Shkreli jacked up a generic drug 5,000% overnight. That’s how insulin, discovered over a century ago, still costs hundreds of dollars in the U.S., but is nearly free in Canada.

This isn’t about innovation. It’s about control.
And control is protected through lobbying.

The pharmaceutical lobby, known as PhRMA, spends more on influencing Congress than any other industry. More than oil. More than guns. More than tech. Every year. Without fail.

They write legislation.
They block price caps.
They delay generics.
They steer public health messaging.
They fund universities, sponsor journals, and quietly co-author the science.

And when lawsuits come? They settle. They admit nothing. They keep going.

This isn’t healthcare.
It’s a subscription model with life or death as the product.

And it works.

Because no matter how angry the public gets…
They still need the pill.